It is intended for use in patients with clinical symptoms of a viral disease with a suspected infection caused by Chikungunya virus.
It is intended for use in patients with clinical symptoms of a viral disease with a suspected infection caused by Zika virus.
It is intended for use in patients with clinical symptoms of a viral disease with a suspected infection caused by Dengue virus.
The kit is recommended for use in patients with clinical symptoms of malaria with a suspected infection caused by representatives of the Plasmodium genus.
The kit is recommended for use in patients with clinical symptoms of malaria with a suspected infection caused by representatives of the Plasmodium genus.
The kit is designed to detect polymorphisms associated with drug resistance to second-line chemotherapy drugs (aminoglycosides and fluoroquinolones) and their analogues.